Signals TranslationalPerkinElmer
|
||||||
Related Products
|
||||||
About
Koneksa is a leading digital biomarker company for the pharmaceutical and biotechnology industries, specializing in developing, testing, and validating digital biomarkers to help clients understand the impact of their treatments on patients. Founded in 2013, Koneksa provides end-to-end remote clinical trial support, leveraging digital health technology, therapeutic expertise, and rapid patient-friendly remote data collection to gain better insights into patient health. Their validated, novel data algorithms are ready to deploy in treatment development programs, enabling the identification of signals earlier and faster than traditional measures. Koneksa's cloud-based SaaS platform allows multiple endpoints to be fed in real-time, giving immediate access to data and empowering confident, cost-saving decisions early in trials. The platform's ability to collect high-volume remote data with increased frequency offers ecologically valid measures and opportunities to reduce sample size.
|
About
With visual analytics powered by TIBCO Spotfire®, PerkinElmer Signals Translational provides all the necessary tools to harmonize, manage, search, aggregate and analyze data consistently across large datasets for use in translational research in a highly scalable manner. Powered by the industry-leading visual analytics platform TIBCO Spotfire®, Signals Translational enables precision medicine studies with the most advanced biomarker discovery and patient stratification solution available today. The Linear Mixed Effect App (LME) in Signals Translational allows scientists to rank the effect of multiple variables on a phenotype of interest, with the option to correct the effect of random variables in the analysis. The genes with the strongest impact on cancer stage progression can be identified independently of the origin of the patients. With the advantage of properly handling missing values and outliers, LME models are an effective tool to identify potential biomarkers.
|
|||||
Platforms Supported
Windows
Mac
Linux
Cloud
On-Premises
iPhone
iPad
Android
Chromebook
|
Platforms Supported
Windows
Mac
Linux
Cloud
On-Premises
iPhone
iPad
Android
Chromebook
|
|||||
Audience
Pharmaceutical and biotechnology companies seeking a tool to optimize their clinical trials
|
Audience
Professionals requiring an advanced data access and analytics solution for biomarker discovery and patient stratification
|
|||||
Support
Phone Support
24/7 Live Support
Online
|
Support
Phone Support
24/7 Live Support
Online
|
|||||
API
Offers API
|
API
Offers API
|
|||||
Screenshots and Videos |
Screenshots and Videos |
|||||
Pricing
No information available.
Free Version
Free Trial
|
Pricing
No information available.
Free Version
Free Trial
|
|||||
Reviews/
|
Reviews/
|
|||||
Training
Documentation
Webinars
Live Online
In Person
|
Training
Documentation
Webinars
Live Online
In Person
|
|||||
Company InformationKoneksa
Founded: 2013
United States
www.koneksahealth.com
|
Company InformationPerkinElmer
Founded: 1937
United States
perkinelmerinformatics.com/products/clinical-translational/signals-translational/
|
|||||
Alternatives |
Alternatives |
|||||
|
|
||||||
|
|
||||||
|
|
||||||
|
|
||||||
Categories |
Categories |
|||||
Integrations
Signals Research Suite
|
||||||
|
|
|